330 related articles for article (PubMed ID: 35082127)
21. [Clinical analysis of 3 cases of eosinophilic granulomatosis with polyangiitis].
Shi X; Qiu RH; Lai ZD; Qiu MZ; Wei SS; Xie JX; Zhang XX; Deng FG; Li J; Gu YY; Dai L; Zhang QL; Zhang NF; Li SY; Chen RC
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):783-786. PubMed ID: 30347550
[No Abstract] [Full Text] [Related]
22. Radiological and Clinical Features of Eosinophilic Granulomatosis with Polyangiitis.
Xu XL; Song W; Sui X; Song L; Du QN; Wang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):617-620. PubMed ID: 27825424
[TBL] [Abstract][Full Text] [Related]
23. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.
Yılmaz I; Bahçecioğlu SN; Türk M; Tutar N; Oymak FS; Gülmez İ
J Asthma; 2019 Feb; 56(2):111-117. PubMed ID: 29611776
[TBL] [Abstract][Full Text] [Related]
24. Biological Modulators in Eosinophilic Diseases.
Sriaroon P; Ballow M
Clin Rev Allergy Immunol; 2016 Apr; 50(2):252-72. PubMed ID: 25129490
[TBL] [Abstract][Full Text] [Related]
25. Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders.
Makiya MA; Khoury P; Kuang FL; Mata AD; Mahmood S; Bowman A; Espinoza D; Kovacs N; Brown T; Holland N; Wetzler L; Ware JM; Dyer AM; Akuthota P; Bochner BS; Chinchilli VM; Gleich GJ; Langford C; Merkel PA; Specks U; Weller PF; Wechsler ME; Prussin C; Fay MP; Klion AD
Allergy; 2023 Jan; 78(1):258-269. PubMed ID: 35971862
[TBL] [Abstract][Full Text] [Related]
26. Churg-Strauss syndrome.
Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
[TBL] [Abstract][Full Text] [Related]
27. Severe Asthma and Biologics: Managing Complex Patients.
Matucci A; Micheletto C; Vultaggio A
J Investig Allergol Clin Immunol; 2023 Jun; 33(3):168-178. PubMed ID: 36059229
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
Raffray L; Guillevin L
Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps and EGPA.
Contro G; Brescia G; Alessandrini L; Barion U; Padoan R; Frigo AC; Schiavon F; Marioni G
Clin Rheumatol; 2021 May; 40(5):1949-1957. PubMed ID: 33094393
[TBL] [Abstract][Full Text] [Related]
30. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
31. Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault A; Jayne D; Guillevin L; Cordier JF;
Eur Respir J; 2016 Nov; 48(5):1429-1441. PubMed ID: 27587545
[TBL] [Abstract][Full Text] [Related]
32. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence.
Caminati M; Micheletto C; Norelli F; Olivieri B; Ottaviano G; Padoan R; Piacentini G; Schiappoli M; Senna G; Menzella F
Expert Opin Biol Ther; 2024; 24(1-2):15-23. PubMed ID: 38197326
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
[TBL] [Abstract][Full Text] [Related]
34. Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.
Folci M; Ramponi G; Arcari I; Zumbo A; Brunetta E
Adv Exp Med Biol; 2021; 1347():197-219. PubMed ID: 34031864
[TBL] [Abstract][Full Text] [Related]
35. "Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients.
Lefèvre G; Leurs A; Gibier JB; Copin MC; Staumont-Sallé D; Dezoteux F; Chenivesse C; Lopez B; Terriou L; Hachulla E; Launay D; Etienne N; Labalette M; DeGroote P; Pontana F; Quemeneur T; Hatron PY; Schleinitz N; Viallard JF; Hamidou M; Martin T; Morati-Hafsaoui C; Groh M; Lambert M; Kahn JE;
J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1329-1340.e3. PubMed ID: 31863912
[TBL] [Abstract][Full Text] [Related]
36. The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions.
Lombardi C; Berti A; Cottini M
Curr Res Immunol; 2022; 3():42-53. PubMed ID: 35496822
[TBL] [Abstract][Full Text] [Related]
37. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
[TBL] [Abstract][Full Text] [Related]
38. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
[TBL] [Abstract][Full Text] [Related]
39. Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes.
Yılmaz İ; Türk M; Bahçecioğlu SN
Autoimmun Rev; 2017 Sep; 16(9):992-993. PubMed ID: 28711579
[No Abstract] [Full Text] [Related]
40. Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.
Ikeda M; Ohshima N; Kawashima M; Shiina M; Kitani M; Suzukawa M
Intern Med; 2022 Mar; 61(5):755-759. PubMed ID: 34393172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
